Abstract
The eight-membered {···HOC=O}2 synthon featured in the crystal structure of 2-amino-4-nitrobenzoic acid (1) is replaced by carboxylic acid···N-pyridine hydrogen bonds in its cocrystals with 2,2′-bipyridine (2/1; 2) and bis(pyridin-2-yl)ketone (1/1; 3) indicating the robust nature of the latter synthon. Disruption of the three-dimensional architecture based on O–H···O and N–H···O(nitro) hydrogen bonds in (1) is evident in the cocrystals which form supramolecular tubes (2) and chains (3) based on O–H···N and N–H···O hydrogen bonding. Compound (1) crystallizes in the monoclinic space group P21/n with a = 3.6291(1) Å, b = 7.7339(3) Å, c = 26.561(1) Å, β = 91.385(2)°, and Z = 4. Compound (2) crystallizes in the monoclinic space group C2/c with a = 27.562(3) Å, b = 6.8300(6) Å, c = 12.923(1) Å, β = 110.593(5)°, and Z = 4. Compound (3) crystallizes in the monoclinic space group P21/c with a = 3.795(3) Å, b = 12.024(8) Å, c = 35.65(2) Å, β = 92.131(6)°, and Z = 4 (determined from synchrotron data).
Graphical Abstract
The carboxylic acid dimer synthon formed in the acid no longer exists in its cocrystals owing to carboxylic acid-OH···N-pyridine interactions. Based on hydrogen bonding a supramolecular tube is formed in the 2/1 cocrystal with 2,2′-bipyridine.
Similar content being viewed by others
References
Zukerman-Schpector J, Tiekink ERT (2008) Z Kristallogr 223:233
Weyna DR, Shattock T, Reddy V, Zaworotko MJ (2008) Cryst Growth Des 8:4533
Morissette SL, Soukasene S, Levinson D, Cima MJ, Almarsson Ö (2003) Proc Natl Acad Sci USA 100:2180
Arora KK, Zaworotko MJ (2009) In: Brittain HG (ed) Polymorphism in pharmaceutical solids, vol 2. Informa Healthcare, New York
Good DJ, Rodríguez-Hornedo N (2009) Cryst Growth Des 9:2252
Schultheiss N, Newman A (2009) Cryst Growth Des 9:2950
Gao X, Friščić T, MacGillivray LR (2004) Angew Chem Int Ed 43:232
Etter MC, Baures PW (1988) J Am Chem Soc 111:639
Huang K-S, Britton D, Etter MC, Byrn SR (1997) J Mater Chem 7:713
Hoekstra MS, Sobieray DM, Schwindt MA, Mulhern TA, Grote TM, Huckabee BK, Hendrickson VS, Franklin LC, Granger EJ, Karrick GL (1997) Org Process Res Dev 1:26
Hori A, Takatani S, Miyamoto TK, Hasegawa M (2009) CrystEngComm 11:567
Han J, Zang S-Q, Mak TCW (2010) Chem Eur J 16:5078
Iimura N, Fujimura Y, Sekine A, Kitagawa S, Ohashi Y (2005) Bull Chem Soc Jpn 78:418
Bhatt PM, Desiraju GR (2008) CrystEngComm 10:1747
Almarsson Ö, Zaworotko MJ (2004) Chem Commun 1889
Bis JA, Vishweshwar P, Weyna DR, Zaworotko MJ (2007) Mol Pharmacol 4:401
Etter MC (1990) Acc Chem Res 23:120
Shattock TR, Arora KK, Vishweshwar P, Zaworotko MJ (2008) Cryst Growth Des 8:4533
Broker GA, Tiekink ERT (2007) CrystEngComm 9:1096
Broker GA, Bettens RPA, Tiekink ERT (2008) CrystEngComm 10:879
Kaiser CR, Pais KC, de Souza MVN, Wardell JL, Wardell SMSV, Tiekink ERT (2009) CrystEngComm 11:1133
Corlette EM, Tiekink ERT (2009) J Chem Crystallogr 39:603
Ellis CA, Miller MA, Spencer J, Zukerman-Schpector J, Tiekink ERT (2009) CrystEngComm 11:1352
Sheldrick GM (2007) SADABS. University of Göttingen, Germany
Hooft RWW (1998) COLLECT data collection software. Nonius B.V., Delft
Otwinowski Z, Minor W (1997) In: Carter CW Jr, Sweet RM (eds) Methods in enzymology, vol 276, Macromolecular crystallography, Part A. Academic Press, New York, pp 307–326
Rigaku MSC (2008) CrystalClear. Rigaku/MSC Inc., The Woodlands
Bruker (2008) Bruker AXS Inc., Madison
Sheldrick GM (2008) Acta Crystalogr A64:211
Farrugia LJ (1997) J Appl Crystallogr 30:565
Brandenburg K (2006) DIAMOND, Version 3.1c. Crystal Impact GbR, Bonn
Farrugia LJ (1999) J Appl Crystallogr 32:827
Spek AL (2009) Acta Crystallogr D65:148
Allen FH (2002) Acta Crystallogr B58:380
Smith G, Wermuth UD, White JM (2002) Acta Crystallogr E58:o1088
Smith G, Wermuth UD, Healy PC (2004) Acta Crystallogr E60:o684
Smith G, Wermuth UD, Healy PC, White JM (2007) Acta Crystallogr E63:o7
Acknowledgments
JLW acknowledges support from CAPES and FAPEMIG (Brazil). The University of Malaya is thanked for support this research (UMRG RG125/10AFR). The use of the EPSRC X-ray crystallographic service at the University of Southampton, England, Prof. W. Clegg and the synchrotron component, based at Daresbury, and the valuable assistance of the staff at those centers are gratefully acknowledged.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Wardell, J.L., Tiekink, E.R.T. Crystal and Molecular Structures of 2-Amino-4-Nitrobenzoic Acid and Its Cocrystals with 2,2′-Bipyridine (2/1) and Bis(pyridin-2-yl)ketone (1/1). J Chem Crystallogr 41, 1418–1424 (2011). https://doi.org/10.1007/s10870-011-0114-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10870-011-0114-7